[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"emg\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:emg":32},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,55,89,125,158,181],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":33,"overallStatus":42,"whyStopped":4,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":54},"100646720","assessment-of-effectiveness-of-pelvic-floor-muscle-training-with-biofeedback-in-male-with-hypogonadism-and-erectile-dysfunction-100646720",false,"NCT07687173","Assessment of Effectiveness of Pelvic Floor Muscle Training With Biofeedback in Male With Hypogonadism and Erectile Dysfunction","Assessment of Effectiveness of Pelvic Floor Muscle Training (PFMT) With Biofeedback in Male With Hypogonadism and Erectile Dysfunction (ED) a Randomised Control Trial.","Inclusion Criteria:\n\n* diagnosed functional hypogonadism\n* diagnosed erectile disorders\n* no diagnosed neurological disorders in pelvic floor area\n* no surgical interventions in pelvic floor area\n* no cancer in its active phase\n* ability to give individual consent\n* consent of participation and following the protocol\n\nExclusion Criteria:\n\n* severe cardiovascular diseases\n* cancer treatment in progress\n* scars and surgical interventions in the pelvic floor area\n* neurological disorders affecting to pelvic floor\n* scars that makes measurements impossible\n* other treatment that affects sexual field similar to this protocol\n* participation in other rehabilitation programme less than 6 months before this programme\n* severe neurological disorders that makes cooperation impossible\n* no technical possibilities to do the measures to the patient\n* disagreement to participate in the programme","MALE","18 Years","60 Years",{"count":20,"type":21},120,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this clinical trial is to learn if Pelvic Floor Muscle Training (PFMT) with biofeedback works to treat Erectile Disorders (ED) in males with Functional Hipogonadism. The main hypothesis is:\n\n1\\. Biofeedback-assisted Pelvic Floor Muscle Training will cause greater improvement in pelvic floor muscle strength and endurance and sexual life than in group without biofeedback and control group in males with Erectile Disorders caused by functional hypogonadism.\n\nThe main questions it aims to answer are:\n\n1. Does biofeedback-assisted pelvic floor muscle training cause greater improvement in pelvic floor muscle strength and endurance and sexual life than in group without biofeedback and control group.\n2. Does using handheld biofeedback trainer device improves technique of Pelvic Floor Muscle Training performance compare to NO biofeedback.\n3. Does 12-week intervention cause greater improvement in analyzed parameters than 6-week intervention.\n4. Does participants using biofeedback will have greater adherence to training protocol than no biofeedback group.\n\nResearch will compare biofeedback-assisted Pelvic Floor Muscle Training to non-biofeedback Pelvic Floor Muscle Training and control group to see if Pelvic Floor Muscle Training works to treat Erectile Disorders in males with functional hypogonadism.\n\nParticipants will:\n\n1. Be measured using questionnaires and pelvic floor muscle electromyography\n2. Do Pelvic Floor Muscle Training for 12 weeks\n3. Provide a diary of their training routine\n4. Have repeated measurements in 6 and 12 weeks",[27,28,29,30,31,32],"Erectile Disfunction","Hypogonadal Males","Functional Hypogonadism","Pelvic Floor Muscle Exercise","Biofeedback Training","EMG",[34,35,29,36,37,38,39,40,41,32],"ED","Erectile Disoreders","Hyopogonadal males","Physiotherapy","PFMT","Pelvic Floor Muscles","Biofeedback","pelvic floor exercise","NOT_YET_RECRUITING","2026-07-03",{"date":45,"type":46},"2026-07-07","ACTUAL",{"date":48,"type":21},"2026-07-01",{"date":50,"type":21},"2029-06-01",{"name":52,"class":53},"Poznan University of Physical Education","OTHER",1,{"id":56,"slug":57,"hasResults":11,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":4,"eligibilityCriteria":60,"healthyVolunteers":61,"sex":62,"minAge":17,"maxAge":63,"enrollmentInfo":64,"targetDuration":4,"studyType":22,"phases":66,"briefSummary":67,"conditions":68,"keywords":73,"overallStatus":42,"whyStopped":4,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":88},"100642340","the-effect-of-lateral-wedge-insoles-on-lower-limb-biomechanics-muscle-activity-and-knee-adduction-moment-during-walking-and-running-100642340","NCT07639411","The Effect of Lateral Wedge Insoles on Lower Limb Biomechanics, Muscle Activity and Knee Adduction Moment During Walking and Running","Inclusion Criteria:\n\n* Being able to walk and run 10 meters without assistance\n* Not having sustained any injury to the lower extremities, pelvis, or trunk within the past 12 months\n* Not having received any treatment for the lower extremities, pelvis, or trunk within the past 6 months\n* Shoe size must be between EU 36 (22 cm) and EU 45 (28 cm) according to European Union (EU) standards\n* Must have scored between 0 and +5 on the Foot Posture Index scale for both feet\n* Have scored between 0 and 20 on the Revised Foot Function Index questionnaire\n* Have a body mass index (BMI) between 18 and 25 kg\u002Fm²\n\nExclusion Criteria:\n\n* Having cognitive impairment, vision or hearing problems, or a systemic disease that could affect overall health\n* Having deformities, contractures, or any other abnormalities in the trunk or lower extremities that could affect participation\n\n  • Having a diagnosed foot or ankle deformity (e.g., pes planus, pes cavus, hallux valgus, etc.)\n* Having any neurological or muscular disorder\n* Being an active professional athlete\n* Failure to sign the informed consent form",true,"ALL","40 Years",{"count":65,"type":21},30,[24],"The aim of this prospective, randomized, single-group interventional study is to use quantitative methods to investigate the acute effects of using lateral-wedge insoles on lower extremity biomechanics, muscle activation patterns, and knee adduction moment during walking and running activities in healthy individuals aged 18-40. The primary research questions it seeks to answer are as follows:\n\n* Do lateral wedge insoles cause a significant change in knee adduction moment?\n* Do lateral wedge insoles change lower extremity biomechanics during walking and running?\n* Do lateral wedge insoles change the activation patterns of lower extremity muscles during walking and running? To compare the effectiveness of lateral wedge insoles, participants will randomly use insoles with 0 (neutral), 5, and 10-degree angles.\n\nParticipants will do the following:\n\n* Put on the shoes and insoles provided to you in the motion analysis laboratory and complete the walking and running protocols, each taking 1 minute, on the treadmill.\n* While walking at your normal walking speed, step so that your dominant leg is positioned over the force plate.\n* Repeat all of this for the insoles at the other two angles.",[69,70,71,72,32],"Biomechanical Changes","Gait Biomechanics","Gait Analysis in Healthy Subjects","Running Kinematics",[74,75,76,77,78],"Lateral Wedges İnsoles","Knee Adduction Moment","Gait Analysis","Running Analysis","EMG Activity","2026-06-06",{"date":81,"type":46},"2026-06-10",{"date":83,"type":21},"2026-06",{"date":85,"type":21},"2027-06",{"name":87,"class":53},"Ankara Yildirim Beyazıt University",2,{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":4,"eligibilityCriteria":95,"healthyVolunteers":11,"sex":62,"minAge":17,"maxAge":96,"enrollmentInfo":97,"targetDuration":4,"studyType":22,"phases":99,"briefSummary":100,"conditions":101,"keywords":109,"overallStatus":115,"whyStopped":4,"lastUpdateSubmitDate":116,"lastUpdatePostDateStruct":117,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":123,"locationsCount":88},"100623769","brain-stimulation-combined-with-watching-hand-movements-to-improve-hand-recovery-in-chronic-stroke-100623769","NCT07400939","Brain Stimulation Combined With Watching Hand Movements to Improve Hand Recovery in Chronic Stroke","Investigating The Neurophysiological Mechanisms Of Transcranial Direct Current Stimulation Combined With Action Observation Therapy On Hand Muscle Neuroplasticity in Chronic Stroke","Inclusion Criteria:\n\n* Adults aged 18 to 59 years\n* Single episode of unilateral stroke and weakness in hand muscles 6 to 24 months post-stroke\n* No excessive spasticity of the upper limb, defined as grade two or less on Modified Ashworth Scale\n\nExclusion Criteria:\n\n* Patients diagnosed with posterior circulation infarction\n* Unable to follow commands due to poor cognitive function\n* Unilateral neglect\n* Homonymous hemianopia\n* Other existing neurological disorders that lead to poor hand function\n* Grade four or five hand muscle strength.","59 Years",{"count":98,"type":21},60,[24],"This study investigates the neurophysiological mechanisms underlying the combined use of transcranial direct current stimulation (tDCS) and action observation therapy (AOT) for hand motor recovery in individuals with stroke. Background: While both tDCS and AOT have shown promise individually for stroke rehabilitation, the neural mechanisms of their combined effects remain unclear. Understanding these mechanisms could optimise rehabilitation protocols and improve functional outcomes. Intervention: Participants will receive 10 sessions of anodal tDCS over the ipsilesional motor cortex combined with AOT over two weeks in a clinical setting, followed by 8 weeks of home-based AOT practice. Control groups will receive tDCS alone or AOT alone. Neurophysiological changes will be assessed using motor evoked potentials (MEPs) to evaluate corticospinal excitability. Clinical hand function will be assessed using standardised outcome measures. Measurements: Assessments will be conducted at baseline, during intervention (week 2), and after the home practice phase (week 10) to evaluate neuroplastic changes. Significance: This study will provide mechanistic insights into how neuromodulation and observational learning interact to promote motor recovery, informing evidence-based rehabilitation strategies for stroke survivors in Malaysia and globally. Study Design: Randomised controlled trial with three parallel arms, recruiting 60 participants with chronic stroke from Sabah, Malaysia.",[102,103,104,105,106,32,107,108],"Stroke","tDCS","Action Observation Therapy","Hand","Motor Evoked Potential","Neuroplasticity","Neurophysiological Assessment",[110,111,112,113,114],"stroke rehabilitation","transcranial direct current stimulation","action observation therapy","neuroplasticity","neurophysiological","RECRUITING","2026-05-07",{"date":118,"type":46},"2026-05-12",{"date":120,"type":46},"2026-04-01",{"date":122,"type":21},"2028-01-20",{"name":124,"class":53},"Universiti Malaysia Sabah",{"id":126,"slug":127,"hasResults":11,"nctId":128,"briefTitle":129,"officialTitle":129,"acronym":130,"eligibilityCriteria":131,"healthyVolunteers":11,"sex":62,"minAge":4,"maxAge":4,"enrollmentInfo":132,"targetDuration":134,"studyType":135,"phases":4,"briefSummary":136,"conditions":137,"keywords":144,"overallStatus":115,"whyStopped":4,"lastUpdateSubmitDate":149,"lastUpdatePostDateStruct":150,"startDateStruct":152,"completionDateStruct":154,"leadSponsor":156,"locationsCount":88},"100605729","ultrasound-evaluation-of-hematoma-risk-after-needle-emg-in-patient-on-doac-therapy-100605729","NCT07166302","Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy","U-HAND","Inclusion Criteria:\n\n* Subjects must understand the nature of the study and must provide signed and dated written informed consent prior to conducting any study-related procedures\n* Willing and able to comply with all protocol procedures\n* subjects confirmed the daily (and recent) intake od direct anticoagulants in strandard dosing.\n* no other antitrombotic drug therapy (e.g. acetylsalicyl acid, clopidogrel, ticagralol, low molecular weight heparin or second direct anticoagulant) is taken.\n\nExclusion Criteria:\n\n* Any clinically significant medical or psychiatric condition or medical history that, in the opinion of the investigator, would interfere with the subject's ability to participate in the study or increase the risk of participation for that subject\n* other antitrombotic drug therapy (e.g. acetylsalicyl acid, clopidogrel, ticagralol, low molecular weight heparin or second direct anticoagulant) is recently taken.",{"count":133,"type":21},70,"7 Days","OBSERVATIONAL","Approximately 30 minutes after needle EMG, patients who are taking direct oral anticoagulants (DOACs) will undergo an ultrasound examination to evaluate for the presence of possible intramuscular hematomas at the muscles where the EMG needle was inserted. These hematomas are considered a potential adverse effect of needle EMG.\n\nThe aim of the study is to determine whether needle EMG can be considered a safe procedure in this group of patients, without posing a risk of intramuscular hematoma formation.",[138,139,32,140,141,142,143],"Direct Acting Anticoagulant Adverse Reaction","Needle Injury","Peripheral Neuropathies","Mononeuropathies","Polyneuropathies","Neuromuscular Diseases (NMD)",[145,146,147,148],"electromyography","hematoma","ultrasonography","anticoagulants","2025-09-03",{"date":151,"type":46},"2025-09-10",{"date":153,"type":21},"2025-09",{"date":155,"type":21},"2026-12-31",{"name":157,"class":53},"Masaryk University",{"id":159,"slug":160,"hasResults":11,"nctId":161,"briefTitle":162,"officialTitle":162,"acronym":4,"eligibilityCriteria":163,"healthyVolunteers":11,"sex":62,"minAge":17,"maxAge":164,"enrollmentInfo":165,"targetDuration":4,"studyType":22,"phases":167,"briefSummary":168,"conditions":169,"keywords":4,"overallStatus":115,"whyStopped":4,"lastUpdateSubmitDate":172,"lastUpdatePostDateStruct":173,"startDateStruct":175,"completionDateStruct":177,"leadSponsor":179,"locationsCount":54},"100509032","gait-analysis-in-patients-with-hemiplegia-using-insole-splint-100509032","NCT05908149","Gait Analysis in Patients With Hemiplegia Using Insole Splint.","Inclusion Criteria:\n\n* Patients that can walk with or without the splint, having their first stroke episode at least two months ago and their hospitalisation period does not overcome six months, having also a diagnosis from a neurologist coming with a Brain CT-scan.\n* Patients must have use the insole splint during physiotherapy sessions for at least 1 week before their inclusion in the trial.\n* Patients must be able to communicate and fully understand the instructions given by the researchers.\n* Researchers are going to try to have a sex ratio 50\u002F50.\n* Patients' age is going to be between 18-70 years.\n* Functional Ambulation Category: FAC \\> 2\n* Modified Ashworth Scale of the affected lower Limb (MAS): MAS ≤2\n* Normal Gait before the stroke.\n\nExclusion Criteria:\n\n* Peripheral Neurological Damage.\n* Past or ongoing orthopedic or reumatologic disease that bothers patient's gait.\n* Past damage of the Central Nervous System.\n* Dermatologic problems or human factors that limitate the use of insole splint.\n* Patients must not have used intramuscular botox injection recently.\n* Patients with low motivation and low perception are also excluded.","70 Years",{"count":166,"type":21},12,[24],"The goal of this clinical trial is to compare the gait of patients with hemiplegia, with or without the use of insole splint. The main questions it aims to answer are:\n\nDoes the insole splint improve the gait of these patients? Does any difference exist in the use of muscles?\n\nParticipants will have to walk in the gait analysis' aisle with and without the insole splint, using wireless EMG device.",[170,171,32],"Gait, Hemiplegic","Splints","2024-12-04",{"date":174,"type":46},"2024-12-06",{"date":176,"type":46},"2023-04-12",{"date":178,"type":21},"2025-12-31",{"name":180,"class":53},"University of Ioannina",{"id":182,"slug":183,"hasResults":11,"nctId":184,"briefTitle":185,"officialTitle":185,"acronym":4,"eligibilityCriteria":186,"healthyVolunteers":11,"sex":62,"minAge":187,"maxAge":63,"enrollmentInfo":188,"targetDuration":4,"studyType":135,"phases":4,"briefSummary":189,"conditions":190,"keywords":4,"overallStatus":115,"whyStopped":4,"lastUpdateSubmitDate":193,"lastUpdatePostDateStruct":194,"startDateStruct":196,"completionDateStruct":198,"leadSponsor":200,"locationsCount":54},"100550058","the-effect-of-bmi-on-gluteus-maximum-activity-in-adulthood-with-sacroiliac-dysfunction-100550058","NCT06442124","The Effect of BMI on Gluteus Maximum Activity in Adulthood With Sacroiliac Dysfunction","Inclusion Criteria:\n\n\\- adulthood with sacroiliac dysfunction\n\n* Their ages will range from 20-40 years old.\n* Their BMI will be less than 20- 30kg\u002Fm2.\n* All of them suffer from mild to moderate degree of sacroiliac pain.\n* The subjects complain from sacroiliac pain for 1 month ago\n\nExclusion Criteria:\n\n* Exclusion criteria were a history of any of the following condition:\n\n  * inflammatory diseases or any rheumatic disorders,\n  * a history of vertebral fractures\n  * surgical spinal fixation.\n  * •any neurological disorders like MS","20 Years",{"count":98,"type":21},"PURPOSE:\n\nThis study will be conducted to investigate the effect of BMI on gluteus maximum activity in adulthood with sacroiliac dysfunction BACKGROUND: Sacroiliac joint (SIJ) pain is pain arising from SIJ structures and SIJ dysfunction (SIJD) generally refers to aberrant position or movement of SIJ structures . An estimated 15-30% of all low back pain cases are due to SIJ pain The present study will be conducted to add a new information to the body of knowledge of physical therapy profession as it will investigate the effect of BMI on gluteus maximum activity in adulthood with sacroiliac dysfunction\n\nHYPOTHESES:\n\n. •There will be no effect of BMI on gluteus maximum activity in adulthood with sacroiliac dysfunction\n\nRESEARCH QUESTION:\n\n* Do BMI has an effect on gluteus maximum activity in adulthood with sacroiliac dysfunction?",[191,192,32],"Sacroiliac Joint Dysfunction","Obesity","2024-06-02",{"date":195,"type":46},"2024-06-04",{"date":197,"type":46},"2024-05-12",{"date":199,"type":21},"2024-06-30",{"name":201,"class":53},"Ahram Canadian University"]